Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Depreciation & Amortization (CF) (2016 - 2026)

Conmed filings provide 17 years of Depreciation & Amortization (CF) readings, the most recent being $4.2 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 1.44% to $4.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $17.1 million, a 1.71% increase, with the full-year FY2025 number at $17.1 million, up 3.24% from a year prior.
  • Depreciation & Amortization (CF) hit $4.2 million in Q1 2026 for Conmed, up from $4.1 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $4.5 million in Q2 2025 to a low of $3.9 million in Q3 2023.
  • Median Depreciation & Amortization (CF) over the past 5 years was $4.1 million (2025), compared with a mean of $4.1 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): fell 15.24% in 2022 and later grew 7.23% in 2025.
  • Conmed's Depreciation & Amortization (CF) stood at $4.0 million in 2022, then rose by 0.62% to $4.1 million in 2023, then increased by 3.63% to $4.2 million in 2024, then decreased by 3.17% to $4.1 million in 2025, then increased by 2.66% to $4.2 million in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $4.2 million (Q1 2026), $4.1 million (Q4 2025), and $4.4 million (Q3 2025) per Business Quant data.